{"id":3578,"date":"2021-10-13T15:09:57","date_gmt":"2021-10-13T15:09:57","guid":{"rendered":"https:\/\/mirm-pitt.net\/technologies\/?post_type=avada_portfolio&p=3578"},"modified":"2021-10-13T15:09:57","modified_gmt":"2021-10-13T15:09:57","slug":"non-gelling-soluble-extracellular-matrix-with-biological-activity-2","status":"publish","type":"avada_portfolio","link":"https:\/\/mirm-pitt.net\/technologies\/patents\/non-gelling-soluble-extracellular-matrix-with-biological-activity-2\/","title":{"rendered":"Non-gelling soluble extracellular matrix with biological activity"},"content":{"rendered":"

Non-gelling soluble extracellular matrix with biological activity<\/h2>\n<\/div>
<\/div><\/div><\/div>

Inventors: <\/strong>Stephen F. Badylak, Timothy Joseph Keane, Jr., Lisa Jane White<\/p>\n

Patent Number: <\/strong>US10736991B2<\/p>\n

\n
\n
\n

Abstract<\/h3>\n
\n
\n
Provided are methods for preparing non-gelling, solubilized extracellular matrix (ECM) materials useful as cell growth substrates. Also provided are compositions prepared according to the methods as well as uses for the compositions. In one embodiment a device, such as a prosthesis, is provided which comprises an inorganic matrix into which the non-gelling, solubilized ECM composition is dispersed to facilitate in-growth of cells into the ECM and thus adaptation and\/or attachment of the device to a patient. In another embodiment, the composition is delivered intraarticularly, intrathecally, intraoccularly, intracranially, and into pleural space.<\/div>\n<\/section>\n<\/div>\n<\/section>\n<\/div>\n<\/div>\n<\/div>
<\/div>
<\/div>
<\/div>